Assignee
GEMINI THERAPEUTICS INC
US·0 granted patents·5 pending applications·0 citations·filing 2018–2019
Top patents by PatentIndex Score
5 records- 0151US2020291427A1Crispr-based therapeutics for targeting htra1 and methods of useGEMINI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0251US2020270614A1RNAi-BASED THERAPEUTICS FOR TARGETING HTRA1 AND METHODS OF USEGEMINI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0350US2020325481A1Antisense-based therapeutics for targeting htra1 and methods of useGEMINI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0439US2021371480A1Compositions and methods for treating age-related macular degeneration and other diseasesGEMINI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0534US2021188927A1Compositions and methods for treating age-related macular degenerationGEMINI THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GEMINI THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →